BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pirola CJ, Sookoian S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J Gastroenterol 2018; 24(15): 1601-1615 [PMID: 29686467 DOI: 10.3748/wjg.v24.i15.1601]
URL: https://www.wjgnet.com/1007-9327/full/v24/i15/1601.htm
Number Citing Articles
1
Vanessa D. Mello, Ratika Sehgal, Ville Männistö, Anton Klåvus, Emma Nilsson, Alexander Perfilyev, Dorota Kaminska, Zong Miao, Päivi Pajukanta, Charlotte Ling, Kati Hanhineva, Jussi Pihlajamäki. Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipidsLiver International 2021; 41(4): 754 doi: 10.1111/liv.14743
2
Noemí Cabré, Fedra Luciano-Mateo, Gerard Baiges-Gayà, Salvador Fernández-Arroyo, Elisabet Rodríguez-Tomàs, Anna Hernández-Aguilera, Marta París, Fàtima Sabench, Daniel Del Castillo, José López-Miranda, Javier A. Menéndez, Jordi Camps, Jorge Joven. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics 2020; 51(3): 374 doi: 10.1111/apt.15606
3
Cheng Hu, Weiping Jia, Jiarui Wu. Multi-omics profiling: the way toward precision medicine in metabolic diseasesJournal of Molecular Cell Biology 2021;  doi: 10.1093/jmcb/mjab051
4
José M Mato, Cristina Alonso, Mazen Noureddin, Shelly C Lu. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2019; 25(24): 3009-3020 doi: 10.3748/wjg.v25.i24.3009
5
Elisa Gurian, Pablo Giraudi, Natalia Rosso, Claudio Tiribelli, Deborah Bonazza, Fabrizio Zanconati, Michela Giuricin, Silvia Palmisano, Nicolò de Manzini, Valter Sergo, Alois Bonifacio. Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopyAnalytica Chimica Acta 2020; 1110: 190 doi: 10.1016/j.aca.2020.02.040
6
Alanah Pieters, Eva Gijbels, Bruno Cogliati, Pieter Annaert, Lindsey Devisscher, Mathieu Vinken. Biomarkers of cholestasisBiomarkers in Medicine 2021; 15(6): 437 doi: 10.2217/bmm-2020-0691
7
Lucia Carulli, Giulia Zanca, Filippo Schepis, Erica Villa. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)Metabolites 2019; 9(2): 25 doi: 10.3390/metabo9020025
8
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLDJournal of Clinical Medicine 2020; 9(3): 870 doi: 10.3390/jcm9030870
9
Silvia Sookoian, Carlos J. Pirola. Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biologyClinical and Molecular Hepatology 2020; 26(4): 461 doi: 10.3350/cmh.2020.0136
10
Carlos J. Pirola, Silvia Sookoian. The lipidome in nonalcoholic fatty liver disease: actionable targetsJournal of Lipid Research 2021; 62: 100073 doi: 10.1016/j.jlr.2021.100073
11
Min-Ae Song, Thomas Ernst, Maarit Tiirikainen, Jörg Tost, Lynne R. Wilkens, Linda Chang, Laurence N. Kolonel, Loïc Le Marchand, Unhee Lim. Methylation of imprinted IGF2 regions is associated with total, visceral, and hepatic adiposity in postmenopausal womenEpigenetics 2018; 13(8): 858 doi: 10.1080/15592294.2018.1518100
12
Juqiang Han, Xiang Zhang. Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.653293
13
José F. Català-Senent, Marta R. Hidalgo, Marina Berenguer, Gopanandan Parthasarathy, Harmeet Malhi, Pablo Malmierca-Merlo, María de la Iglesia-Vayá, Francisco García-García. Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studiesBiology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-021-00368-1
14
Urho M. Kujala, Jani P. Vaara, Heikki Kainulainen, Tommi Vasankari, Elina Vaara, Heikki Kyröläinen. Associations of Aerobic Fitness and Maximal Muscular Strength With Metabolites in Young MenJAMA Network Open 2019; 2(8): e198265 doi: 10.1001/jamanetworkopen.2019.8265
15
Laurent Castera, Mireen Friedrich-Rust, Rohit Loomba. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver DiseaseGastroenterology 2019; 156(5): 1264 doi: 10.1053/j.gastro.2018.12.036
16
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and ManagementAdvances in Therapy 2021; 38(5): 2130 doi: 10.1007/s12325-021-01690-1
17
Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun Sanyal, Brent Neuschwander-Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth Brunt, Elisabetta Bugianesi, Hannele Yki-Järvinen, Henning Grønbæk, Helena Cortez-Pinto, Jacob George, Jiangao Fan, Luca Valenti, Manal Abdelmalek, Manuel Romero-Gomez, Mary Rinella, Marco Arrese, Mohammed Eslam, Pierre Bedossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramon Bataller, Rohit Loomba, Silvia Sookoian, Shiv K. Sarin, Stephen Harrison, Takumi Kawaguchi, Vincent Wai-Sun Wong, Vlad Ratziu, Yusuf Yilmaz, Zobair Younossi. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseGastroenterology 2020; 158(7): 1999 doi: 10.1053/j.gastro.2019.11.312
18
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems BiologyHepatology 2020; 72(1): 330 doi: 10.1002/hep.31229
19
Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel Lefever, Xiang Li, Celeste Reese, Erin E Kershaw, Vijay Yechoor, Jaideep Behari, Alejandro Soto-Gutierrez, Larry Vernetti, Andrew Stern, Albert Gough, Mark T Miedel, D Lansing Taylor. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensorsExperimental Biology and Medicine 2021; : 153537022110092 doi: 10.1177/15353702211009228
20
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, Enara Arretxe, Cristina Alonso, Melania Gaggini, Julia Brosnan, Quentin M. Anstee, Oscar Millet, Pablo Ortiz, Jose M. Mato, Jean-Francois Dufour, Matej Orešič. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic testsNature Reviews Gastroenterology & Hepatology 2021;  doi: 10.1038/s41575-021-00502-9
21
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-ChipCell Reports 2021; 36(3): 109393 doi: 10.1016/j.celrep.2021.109393
22
Sònia Torres, Sara Samino, Pere Ràfols, Manuela Martins-Green, Xavier Correig, Noelia Ramírez. Unravelling the metabolic alterations of liver damage induced by thirdhand smokeEnvironment International 2021; 146: 106242 doi: 10.1016/j.envint.2020.106242
23
Dana Goldner, Joel E. Lavine. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and ChallengesGastroenterology 2020; 158(7): 1967 doi: 10.1053/j.gastro.2020.01.048
24
Gwyneth Soon, Aileen Wee. Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspectiveClinical and Molecular Hepatology 2021; 27(1): 44 doi: 10.3350/cmh.2020.0181
25
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) EnzymesPharmaceuticals 2020; 13(9): 222 doi: 10.3390/ph13090222
26
Farzaneh Iravani, Neda Hosseini, Majid Mojarrad. Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic SteatohepatitisMiddle East Journal of Digestive Diseases 2018; 10(4): 213 doi: 10.15171/mejdd.2018.113
27
Claudio Fiocchi. Biomarkers in Inflammatory Bowel Diseases2019; : 353 doi: 10.1007/978-3-030-11446-6_30
28
Alia Hadefi, Delphine Degré, Eric Trépo, Christophe Moreno. Noninvasive diagnosis in alcohol‐related liver diseaseHealth Science Reports 2020; 3(1) doi: 10.1002/hsr2.146
29
Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese. NAFLD and NASH2020; : 225 doi: 10.1007/978-3-030-37173-9_13
30
Silvia Sookoian, Carlos J Pirola. Repurposing drugs to target nonalcoholic steatohepatitisWorld Journal of Gastroenterology 2019; 25(15): 1783-1796 doi: 10.3748/wjg.v25.i15.1783
31
Lucia Carulli, Giulia Zanca, Filippo Schepis, Erica Villa. Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25Metabolites 2019; 9(4): 70 doi: 10.3390/metabo9040070
32
Manuel Suárez, Núria Canela, Josep M. del Bas, Francesc Puiggròs, Lluís Arola, Antoni Caimari. Comprehensive Foodomics2021; : 14 doi: 10.1016/B978-0-08-100596-5.22826-6
33
Cheng Hu, Tao Wang, Xiaoyu Zhuang, Qiaoli Sun, Xiaochun Wang, Hui Lin, Mingli Feng, Jiaqi Zhang, Qin Cao, Yuanye Jiang. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometryJournal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02820-7